Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol vs Aspirin in Acute Non-Cardioembolic Stroke with Microbleeds
NCT06530537Phase 3Recruiting
- Sponsor
- Zhejiang Provincial People's Hospital
- Start
- Jul 2024
- Primary completion
- Aug 2031
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cilostazol in ischemic stroke, sponsored by Zhejiang Provincial People's Hospital. Started Jul 2024; status: recruiting.
02
Drugs
cilostazol
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06530537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06530537.